On Monday, the transnational pharmaceutical company Pfizer said on Monday that its covid-19 vaccine works for children between 5 and 11 years old and that it will soon seek authorization from the US for this age group, the Associated Press reported.
Dr. Bill Gruber, senior vice president at Pfizer, said a much lower dose was tested for elementary school-age children - one-third the amount in each injection given now. However, after their second dose, children ages 5 to 11 developed levels of antibodies to the coronavirus as strong as adolescents and young adults who receive the regular strength injections.
The children's dose was also safe, with similar or fewer temporary side effects, such as pain in the arms, fever or pain, that teens experience, the AP says.
According to the results of a study announced Monday by the laboratories, they reveal that the Pfizer / BioNTech vaccine against covid-19 is "safe" and "tolerated" by children from 5 to 11 years old, to whom the adapted dose generates a "robust" immune response, reports Agence France-Presse.
The doses of the drug in this group are 10 micrograms per injection, instead of the 30 given to older groups.
They indicated the laboratories that are partial results of a study carried out on 4.500 children between 6 months and 11 years in the United States, Finland, Poland and Spain.
The two companies expect to publish in the fourth quarter the results of the range between 2 and 5 years and from 6 months to two years, which received injections of 3 micrograms, says AFP.
While children have a lower risk of serious illness or death than older people, more than 5 million children in the US have tested positive for COVID-19 since the pandemic began and at least 460 have died, according to the Academy. American Pediatrician. Cases in children have increased as the delta variant spread across the country.